News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Adaptive will work with NCI's Cancer Therapy Evaluation Program to use its ImmunoSeq platform for biomarker discovery in clinical trials.
Stakeholders increasingly highlight the need for better, more standardized tools to validate and compare liquid biopsy tests, and commercial firms have responded.
Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.
Using the grant funding, the investigators are aiming to advance the precision diagnosis and treatment of lung cancer.
New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.
